DiaMedica Therapeutics (DMAC) Return on Equity (2018 - 2026)

DiaMedica Therapeutics has reported Return on Equity for 9 years, with the latest figure at 0.01% in Q1 2026.

• For the quarter ending Q1 2026, Return on Equity changed 0.0% year-over-year to 0.01%; the trailing twelve-month figure through Mar 2026 stood at 0.01% (changed 0.0% YoY), and the FY2025 full-year result was 0.01%, changed 0.0% from the prior year.
• Return on Equity for Q1 2026 stood at 0.01%, down from 0.01% in the prior quarter.
• The five-year high for Return on Equity was 0.0% in Q3 2023, with the low at 0.01% in Q2 2025.
• Historically, Return on Equity has averaged 0.01% across 5 years, with a median of 0.0% in 2022.
• Annual changes were most pronounced in 2022 — Return on Equity changed 0 bps — and 2025, when it slipped 1 bps.
• DiaMedica Therapeutics' Return on Equity stood at 0.0% in 2022, then climbed by 11 bps to 0.0% in 2023, then tumbled by 52 bps to 0.01% in 2024, then slipped by 11 bps to 0.01% in 2025, then decreased by 12 bps to 0.01% in 2026.
• The last three Return on Equity figures came in at 0.01% (Q1 2026), 0.01% (Q4 2025), and 0.01% (Q3 2025), per Business Quant data.